These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22617754)

  • 1. The role of pathway-selective insulin resistance and responsiveness in diabetic dyslipoproteinemia.
    Wu X; Chen K; Williams KJ
    Curr Opin Lipidol; 2012 Aug; 23(4):334-44. PubMed ID: 22617754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NOX4 pathway as a source of selective insulin resistance and responsiveness.
    Wu X; Williams KJ
    Arterioscler Thromb Vasc Biol; 2012 May; 32(5):1236-45. PubMed ID: 22328777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imbalanced insulin action in chronic over nutrition: Clinical harm, molecular mechanisms, and a way forward.
    Williams KJ; Wu X
    Atherosclerosis; 2016 Apr; 247():225-82. PubMed ID: 26967715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scutellariae Radix and Coptidis Rhizoma Improve Glucose and Lipid Metabolism in T2DM Rats via Regulation of the Metabolic Profiling and MAPK/PI3K/Akt Signaling Pathway.
    Cui X; Qian DW; Jiang S; Shang EX; Zhu ZH; Duan JA
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30453687
    [No Abstract]   [Full Text] [Related]  

  • 5. An oxide transport chain essential for balanced insulin action.
    Wu X; Chen K; Williams KJ
    Atherosclerosis; 2020 Apr; 298():42-51. PubMed ID: 32171979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A current update on the use of alpha lipoic acid in the management of type 2 diabetes mellitus.
    Poh ZX; Goh KP
    Endocr Metab Immune Disord Drug Targets; 2009 Dec; 9(4):392-8. PubMed ID: 19601918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An alternative model for studying age-associated metabolic complications: Senescence-accelerated mouse prone 8.
    Liu HW; Chan YC; Wei CC; Chen YA; Wang MF; Chang SJ
    Exp Gerontol; 2017 Dec; 99():61-68. PubMed ID: 28843510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple factors and pathways involved in hepatic very low density lipoprotein-apoB100 overproduction in Otsuka Long-Evans Tokushima Fatty rats.
    Qin B; Anderson RA; Kuzuya T; Kitaura Y; Shimomura Y
    Atherosclerosis; 2012 Jun; 222(2):409-16. PubMed ID: 22546076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NAD(P)H oxidase homolog Nox4 modulates insulin-stimulated generation of H2O2 and plays an integral role in insulin signal transduction.
    Mahadev K; Motoshima H; Wu X; Ruddy JM; Arnold RS; Cheng G; Lambeth JD; Goldstein BJ
    Mol Cell Biol; 2004 Mar; 24(5):1844-54. PubMed ID: 14966267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fumosorinone, a novel PTP1B inhibitor, activates insulin signaling in insulin-resistance HepG2 cells and shows anti-diabetic effect in diabetic KKAy mice.
    Liu ZQ; Liu T; Chen C; Li MY; Wang ZY; Chen RS; Wei GX; Wang XY; Luo DQ
    Toxicol Appl Pharmacol; 2015 May; 285(1):61-70. PubMed ID: 25796170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BMI-related progression of atypical PKC-dependent aberrations in insulin signaling through IRS-1, Akt, FoxO1 and PGC-1α in livers of obese and type 2 diabetic humans.
    Sajan MP; Ivey RA; Farese RV
    Metabolism; 2015 Nov; 64(11):1454-65. PubMed ID: 26386696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of type 2 diabetic mellitus animal models via interactions between insulin and mitogen‑activated protein kinase signaling pathways induced by a high fat and sugar diet and streptozotocin.
    Zhuo J; Zeng Q; Cai D; Zeng X; Chen Y; Gan H; Huang X; Yao N; Huang D; Zhang C
    Mol Med Rep; 2018 Apr; 17(4):5132-5142. PubMed ID: 29393432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin treatment improves human umbilical cord mesenchymal stem cell therapy in a mouse model of type II diabetes mellitus via the PI3K/AKT signaling pathway.
    Aierken A; Li B; Liu P; Cheng X; Kou Z; Tan N; Zhang M; Yu S; Shen Q; Du X; Enkhbaatar BB; Zhang J; Zhang R; Wu X; Wang R; He X; Li N; Peng S; Jia W; Wang C; Hua J
    Stem Cell Res Ther; 2022 Apr; 13(1):164. PubMed ID: 35414044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver-specific inducible nitric-oxide synthase expression is sufficient to cause hepatic insulin resistance and mild hyperglycemia in mice.
    Shinozaki S; Choi CS; Shimizu N; Yamada M; Kim M; Zhang T; Shiota G; Dong HH; Kim YB; Kaneki M
    J Biol Chem; 2011 Oct; 286(40):34959-75. PubMed ID: 21846719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-206 prevents hepatosteatosis and hyperglycemia by facilitating insulin signaling and impairing lipogenesis.
    Wu H; Zhang T; Pan F; Steer CJ; Li Z; Chen X; Song G
    J Hepatol; 2017 Apr; 66(4):816-824. PubMed ID: 28025059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin signaling to hepatic lipid metabolism in health and disease.
    Leavens KF; Birnbaum MJ
    Crit Rev Biochem Mol Biol; 2011 Jun; 46(3):200-15. PubMed ID: 21599535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic Activation of the FAM3C-HSF1-CaM Pathway Attenuates Hyperglycemia of Obese Diabetic Mice.
    Chen Z; Ding L; Yang W; Wang J; Chen L; Chang Y; Geng B; Cui Q; Guan Y; Yang J
    Diabetes; 2017 May; 66(5):1185-1197. PubMed ID: 28246289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis.
    Li S; Brown MS; Goldstein JL
    Proc Natl Acad Sci U S A; 2010 Feb; 107(8):3441-6. PubMed ID: 20133650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oligonol promotes glucose uptake by modulating the insulin signaling pathway in insulin-resistant HepG2 cells via inhibiting protein tyrosine phosphatase 1B.
    Bhakta HK; Paudel P; Fujii H; Sato A; Park CH; Yokozawa T; Jung HA; Choi JS
    Arch Pharm Res; 2017 Nov; 40(11):1314-1327. PubMed ID: 29027136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.